COMPANY PROFILE / #816
Clear Labs
Developer of a comprehensive whole-genome sequencing platform intended to enhance pathogen surveillance and infectious disease outbreak management. The company's platform integrates automated sequencing with advanced bioinformatics, facilitating rapid detection and analysis of pathogens, enabling public health agencies and food safety organizations to improve response times and ensure consumer safety through precise genomic insights.Privately Held (backing)
已融资83
最新估值—
员工数—
成立年份Autogenomics, Molecular Response, Synpromics, Oxford Nanopore Technologies, Flagship Biosciences, Illumina, Pacific BioSciences of California, Qiagen, Bio-Rad Laboratories, Roche, Tecan Trading, Thermo Fisher Scientific, Hologic
公司概况
- Companies
- Clear Labs
- Description
- —
- Website
- San Carlos, CA
- HQ Location
- Developer of a comprehensive whole-genome sequencing platform intended to enhance pathogen surveillance and infectious disease outbreak management. The company's platform integrates automated sequencing with advanced bioinformatics, facilitating rapid detection and analysis of pathogens, enabling public health agencies and food safety organizations to improve response times and ensure consumer safety through precise genomic insights.
- Year Founded
- Autogenomics, Molecular Response, Synpromics, Oxford Nanopore Technologies, Flagship Biosciences, Illumina, Pacific BioSciences of California, Qiagen, Bio-Rad Laboratories, Roche, Tecan Trading, Thermo Fisher Scientific, Hologic
- Keywords
- 2025: 83, 2024: 77, 2023: 60, 2022: 107, 2021: 93, 2020: 66, 2019: 54, 2018: 52 E, 2017: 50, 2016: 15, 2015: 11
- Competitors
- —
- Ownership Status
- —
- Company Financing Status
- Privately Held (backing)
融资与估值
- Total Raised
- 83
- First Financing Date
- —
- First Financing Size
- 10
- First Financing Valuation
- sasan.amini@clearlabs.com
- Last Financing Date
- -0.23%
- Last Financing Deal Type
- 16-Jun-2025
- Last Financing Size
- Later Stage VC
- Last Financing Valuation
- —
- Last Financing Status
- 413.00
- Last Known Valuation
- —
- Last Known Valuation Date
- Later Stage VC
- Last Known Valuation Deal Type
- —
- Valuation Estimate
- 16-Jun-2025
- Valuation Estimate Growth Rate
- abi custom application, analytics platform, bioinformatics data, clinical diagnostics, food safety, genomics sequencing, genomics system, healthcare data analytics, infectious disease, whole genome sequencing
- Active Investors
- Venture Capital-Backed
- # Active Investors
- 12%
- Acquirers
- Alumni Ventures, Athena Capital (New York), B37 Ventures, Codon Capital, Dafgårds, Dentsu Ventures, Exitfund, Falkon Ventures, Felicis, GV, Hamid Barkhordar, HBM Genomics, HBR Genomics, Karl Handelsman, Khosla Ventures, Koru Capital (New York), Menlo Ventures, Miguel Valls, Morgan Stanley, Nimble Partners, Nimble Ventures, Passport Capital, Phi-X Capital, Plug and Play, Prime Partners, Redmile Group, RONA Holdings, SGH Capital, T. Rowe Price Group, Tencent Holdings, Tyson Ventures, Wing Venture Capital
团队与联系人
- Employees
- —
- Employee Growth %
- 2014
- Employee History
- —
- Primary Contact
- 173.35
- Primary Contact Title
- +1 (650) 257-3304
- Primary Contact Email
- Sasan Amini
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- 39.50%
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- 430
- Size Multiple
- —
- Size Multiple % Change
- 413.00
- Size Multiple Change
- 0.00%
- Size Multiple Percentile
- 0.00x
- Majestic Referring Domains
- 16.54x
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- 620
- Success Probability Over Time – 1 Year
- 27%
- Success Probability Over Time – 3 Year
- 46%
- Success Probability Over Time – 5 Year
- Co-Founder, Chief Executive Officer & Board Member
记录来源：public.companies · 原始序号 #816 · 所有字段均按数据库原值展示。